What is Mural Oncology PLC (MURA)?

Mural Oncology PLC (MURA) Stock Analysis

$2.040

0.000 (0.00%)At close

Loading chart…

High: 2.040
Open: 2.030
VWAP: 2.04
Vol: 127.78K
Mkt Cap: —
Low: 2.030
Amount: 260.24K
EV/EBITDA, TTM: 0.55

Mural Oncology plc is Ireland-based clinical-stage oncology company. The Company is a biotechnology company focused on using its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer with the goal of delivering meaningful and clinical benefits to people living with cancer. The Company is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. The lead product candidate, nemvaleukin alfa (nemvaleukin), is an investigational-engineered cytokine fusion protein that selectively binds to the intermediate-affinity interleukin-2 (IL-2) receptor. The Company has also developed engineered therapies targeting the interleukin-18 (IL-18) and interleukin-12 (IL-12) pathways, which have demonstrated therapeutic potential in third-party preclinical and clinical studies.

www.muraloncology.com

Valuation Metrics

The current forward P/E ratio for Mural Oncology PLC (MURA) is -0.78, compared to its 5-year average forward P/E of -0.64.

Forward P/E

Fair

5Y Average P/E

-0.64

Current P/E

-0.78

Overvalued

-0.33

Undervalued

-0.94

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

0.82

Current EV/EBITDA

0.55

Overvalued

1.48

Undervalued

0.15

Forward P/S

Fair

5Y Average P/S

0.08

Current P/S

0.00

Overvalued

0.64

Undervalued

-0.47

Alphio AI Price Scenarios for MURA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%MURA

$2.80

Scenario price

Base

Base · 50%MURA

$2.62

Scenario price

Bear

Bear · 25%MURA

$2.13

Scenario price

Events Timeline

2025-12-05 (ET)